Usages in wwPDB of concept: c_0490
nUsages: 147; SSE string: HEEEEEH
1a1c:B   (THR157) to   (LYS235)  C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(- (CH2)3-CYCLOPENTYL))  |   COMPLEX (TRANSFERASE/PEPTIDE) 
1a81:A    (THR21) to    (GLU95)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
1a81:C   (SER174) to   (LYS247)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
1a81:I   (SER174) to   (LYS247)  CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM  |   COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX 
4gwf:A   (SER118) to   (PRO201)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION  |   ALPHA/BETA PROTEINS, SH2 DOMAIN, PHOSPHATASE DOMAIN, TYROSINE PHOSPHATASE SHP-2, HYDROLASE 
4gwf:B   (SER118) to   (ASN200)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION  |   ALPHA/BETA PROTEINS, SH2 DOMAIN, PHOSPHATASE DOMAIN, TYROSINE PHOSPHATASE SHP-2, HYDROLASE 
2awf:A     (GLY6) to   (ASP130)  STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME E2 G1  |   LIGASE, UBL CONJUGATION PATHWAY, UBIQUITIN-CONJUGATING ENZYME, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC 
2oq1:A    (SER18) to    (ASP92)  TANDEM SH2 DOMAINS OF ZAP-70 WITH 19-MER ZETA1 PEPTIDE  |   TANDEM SH2 DOMAINS, ZAP-70, TYROSINE KINASE, TRANSFERASE 
1aou:F    (GLY13) to    (ARG92)  NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES  |   SH2 DOMAIN, SIGNAL TRANSDUCTION, PEPTIDE COMPLEX, COMPLEX (PROTO-ONCOGENE/EARLY PROTEIN) 
2b3o:A    (SER10) to    (GLN82)  CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1  |   PROTEIN TYROSINE PHOSPHATASE, SHP-1, SIGNALING, HYDROLASE 
1nrv:B   (SER441) to   (ASN519)  CRYSTAL STRUCTURE OF THE SH2 DOMAIN OF GRB10  |   DIMER, SIGNALING PROTEIN 
2ozo:A    (SER16) to    (ASP90)  AUTOINHIBITED INTACT HUMAN ZAP-70  |   INACTIVE ZAP-70, TANDEM SH2, AUTOINHIBITION, ITAM, HYDROGEN BONDING NETWORK, TCR SIGNALING, TRANSFERASE 
1blj:A    (SER20) to    (GLY99)  NMR ENSEMBLE OF BLK SH2 DOMAIN, 20 STRUCTURES  |   SIGNAL TRANSDUCTION, TYROSINE KINASE, TRANSFERASE, PHOSPHOTRANSFERASE, PHOSPHORYLATION 
1blk:A    (SER20) to    (LYS98)  NMR ENSEMBLE OF BLK SH2 DOMAIN USING CHEMICAL SHIFT REFINEMENT, 20 STRUCTURES  |   SIGNAL TRANSDUCTION, TYROSINE KINASE, TRANSFERASE, PHOSPHOTRANSFERASE, PHOSPHORYLATION 
2ple:A    (THR17) to    (HIS87)  NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE  |   PHOSPHORIC DIESTER HYDROLASE 
2c0i:A   (SER129) to   (GLY208)  SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983  |   TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN 
2c0i:B   (SER129) to   (LYS207)  SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983  |   TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN 
2c0o:A   (SER129) to   (GLY208)  SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041  |   TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN 
2c0o:B   (SER129) to   (LYS207)  SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041  |   TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN 
1opk:A   (SER152) to   (VAL224)  STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE  |   TRANSFERASE 
1opl:A   (SER152) to   (VAL224)  STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE  |   TRANSFERASE 
1opl:B   (SER152) to   (VAL224)  STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE  |   TRANSFERASE 
3fsh:A     (HIS0) to   (ALA128)  CRYSTAL STRUCTURE OF THE UBIQUITIN CONJUGATING ENZYME UBE2G2 BOUND TO THE G2BR DOMAIN OF UBIQUITIN LIGASE GP78  |   PROTEIN-PEPTIDE COMPLEX, LIGASE, UBL CONJUGATION PATHWAY, ALTERNATIVE SPLICING, ENDOPLASMIC RETICULUM, MEMBRANE, METAL-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, ZINC, ZINC-FINGER 
1d1z:A  (SER1012) to  (PHE1087)  CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP  |   SH2 DOMAINS, GENE REGULATION 
1d1z:D  (SER4012) to  (PHE4087)  CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP  |   SH2 DOMAINS, GENE REGULATION 
1d4t:A    (SER12) to    (GLN88)  CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH A SLAM PEPTIDE  |   SH2 DOMAIN, TYROSINE KINASE, SIGNAL TRANSDUCTION, PEPTIDE RECOGNITION, SIGNALING PROTEIN 
1d4w:B    (SER12) to    (GLN88)  CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE RECOGNIITON, PEPTIDE RECOGNITION, SIGNAL TRANSDUCTION, LYMPHOPROLIFERATIVE DISEASE, SIGNALING PROTEIN 
2cia:A   (THR291) to   (LYS361)  HUMAN NCK2 SH2-DOMAIN IN COMPLEX WITH A DECAPHOSPHOPEPTIDE FROM TRANSLOCATED INTIMIN RECEPTOR (TIR) OF EPEC  |   SH2-DOMAIN, SH3 DOMAIN, PHOSPHORYLATION, BINDING SPECIFICITY 
2ci9:A   (THR288) to   (LYS357)  NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR  |   PROTEIN-BINDING, SH2-DOMAIN/COMPLEX 
2ci9:B   (THR288) to   (LYS357)  NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR  |   PROTEIN-BINDING, SH2-DOMAIN/COMPLEX 
2cs0:A    (SER24) to    (GLN94)  SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN HSH2D PROTEIN  |   ALX, FLJ14886, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
2cyx:B    (GLY-4) to   (ALA128)  STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME E2 G2 (UBE2G2/UBC7)  |   UBIQUITIN-CONJUGATING ENZYME (E2), UBL CONJUGATION PATHWAY, LIGASE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI 
2dcr:A    (PRO24) to    (GLN92)  FULLY AUTOMATED SOLUTION STRUCTURE DETERMINATION OF THE FES SH2 DOMAIN  |   SH2 DOMAIN, FES, FELINE SARCOMA ONCOGENE, FULLY AUTOMATED STRUCTURE DETERMINATION, FLYA ALGORITHM, TRANSFERASE 
2dlz:A    (GLU24) to    (SER96)  SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN PROTEIN VAV-2  |   RHO FAMILY GUANINE NUCLEOTIDE EXCHANGE FACTOR, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
2rsy:A    (THR88) to   (ASP159)  SOLUTION STRUCTURE OF THE SH2 DOMAIN OF CSK IN COMPLEX WITH A PHOSPHOPEPTIDE FROM CBP  |   SH2 DOMAIN, CSK, CBP, SOLUTION STRUCTURE, TRANSFERASE-SIGNALING PROTEIN COMPLEX 
2rvf:A    (SER14) to    (HIS84)  SOLUTION NMR STRUCTURE OF MONOSIGA BREVICOLLIS CRK/CRKL HOMOLOG (CRKA1) SH2 DOMAIN  |   SIGNAL TRANSDUCTION, PHOSPHOTYROSINE-BINDING DOMAIN, SIGNALING PROTEIN 
2shp:A    (THR12) to    (HIS84)  TYROSINE PHOSPHATASE SHP-2  |   TYROSINE PHOSPHATASE, INSULIN SIGNALING, SH2 PROTEIN 
2shp:B    (THR12) to    (HIS84)  TYROSINE PHOSPHATASE SHP-2  |   TYROSINE PHOSPHATASE, INSULIN SIGNALING, SH2 PROTEIN 
3h8k:A     (GLY3) to   (ALA128)  CRYSTAL STRUCTURE OF UBE2G2 COMPLXED WITH THE G2BR DOMAIN OF GP78 AT 1.8-A RESOLUTION  |   ALPHA BETA, ALL ALPHA, LIGASE, UBL CONJUGATION PATHWAY, ENDOPLASMIC RETICULUM, MEMBRANE, METAL-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSMEMBRANE, ZINC-FINGER 
1fbz:A    (SER11) to    (ALA90)  STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE, NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY  |   SH2 DOMAIN, NONPEPTIDE INHIBITOR, TRANSFERASE 
2eu0:A    (SER17) to    (ASN97)  THE NMR ENSEMBLE STRUCTURE OF THE ITK SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE  |   CIS/TRANS ISOMERIZATION, INTERLEUKIN-2 TYROSINE KINASE, ITK, T-CELL SPECIFIC KINASE, TSK, SRC HOMOLOGY 2, SH2, PROLINE, PHOSPHOTYROSINE BINDING, TRANSFERASE 
4k44:A   (THR674) to   (HIS744)  AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES  |   SH2 DOMAIN, HYDROLASE, PLC-GAMMA1 
4k44:B   (THR674) to   (HIS744)  AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES  |   SH2 DOMAIN, HYDROLASE, PLC-GAMMA1 
4k45:A   (THR674) to   (HIS744)  AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES  |   SH2 DOMAIN, PLC-GAMMA1, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2eyy:A    (SER19) to   (LYS105)  CT10-REGULATED KINASE ISOFORM I  |   SH2, SH3, SIGNALING PROTEIN 
2eyz:A    (SER19) to   (HIS107)  CT10-REGULATED KINASE ISOFORM II  |   SH2, SH3, SIGNALING PROTEIN 
2fci:A    (GLN20) to    (HIS87)  STRUCTURAL BASIS FOR THE REQUIREMENT OF TWO PHOSPHOTYROSINES IN SIGNALING MEDIATED BY SYK TYROSINE KINASE  |   SH2 DOMAIN, PHOSPHOPEPTIDE, SYK KINASE, PLCGAMMA, PLCC, HYDROLASE 
4z32:A   (MET406) to   (TYR481)  CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2  |   JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE 
4z32:B   (MET406) to   (TYR481)  CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2  |   JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE 
4z32:C   (MET406) to   (TYR481)  CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2  |   JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE 
4z32:E   (MET406) to   (TYR481)  CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2  |   JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE 
4z32:F   (MET406) to   (TYR481)  CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2  |   JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE 
4z32:H   (MET406) to   (CYS480)  CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2  |   JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE 
3uyo:A   (SER152) to   (SER222)  CRYSTAL STRUCTURE OF MONOBODY SH13/ABL1 SH2 DOMAIN COMPLEX  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, ATP-BINDING, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX 
1shd:A   (THR157) to   (HIS236)  PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS  |   COMPLEX(TRANSFERASE-PEPTIDE), COMPLEX(TRANSFERASE-PEPTIDE) COMPLEX 
1spr:B    (THR11) to    (HIS90)  BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS  |   TRANSFERASE(PHOSPHOTRANSFERASE) 
2hdv:A   (SER533) to   (ARG605)  CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF THE ADAPTER PROTEIN SH2-B  |   SH2, ADAPTER PROTEIN, SIGNALING PROTEIN 
2hdx:A   (LEU535) to   (ARG605)  CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE  |   SH2, JAK2, PHOSPHOTYROSINE, ADAPTER PROTEIN, SIGNALING PROTEIN 
2hdx:B   (SER533) to   (ARG605)  CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE  |   SH2, JAK2, PHOSPHOTYROSINE, ADAPTER PROTEIN, SIGNALING PROTEIN 
2hdx:D   (SER533) to   (ARG605)  CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE  |   SH2, JAK2, PHOSPHOTYROSINE, ADAPTER PROTEIN, SIGNALING PROTEIN 
3von:C     (PRO5) to   (ALA114)  CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE  |   UBIQUITIN PROTEASE, HYDROLASE-LIGASE COMPLEX 
3vrz:A   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vrz:B   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs1:B   (SER155) to   (TYR231)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA  |   TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs2:A   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[2,3-D]PYRIMIDIN-4-AMINE  |   TYROSINE KINASE, SRC-FAMILY, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs2:B   (SER155) to   (LYS232)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[2,3-D]PYRIMIDIN-4-AMINE  |   TYROSINE KINASE, SRC-FAMILY, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs4:B   (SER155) to   (LYS232)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[2,3- D]PYRIMIDIN-4-AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs5:A   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3- D]PYRIMIDIN-4-AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs7:A   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H- PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2hmh:A    (GLY53) to   (MET128)  CRYSTAL STRUCTURE OF SOCS3 IN COMPLEX WITH GP130(PTYR757) PHOSPHOPEPTIDE.  |   SOCS3, GP130, PTYR, PEPTIDE COMPLEX, CYTOKINE REGULATOR 
4lue:B   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)  |   COCRYSTALLIZATION, SKF86002, FLUORESCENCE, INHIBITOR SCREENING, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2xp1:A   (ASN799) to   (SER863)  STRUCTURE OF THE TANDEM SH2 DOMAINS FROM ANTONOSPORA LOCUSTAE TRANSCRIPTION ELONGATION FACTOR SPT6  |   TRANSCRIPTION, IWS1, HISTONE CHAPERONE, MRNA EXPORT 
2xp1:A   (SER885) to   (LYS953)  STRUCTURE OF THE TANDEM SH2 DOMAINS FROM ANTONOSPORA LOCUSTAE TRANSCRIPTION ELONGATION FACTOR SPT6  |   TRANSCRIPTION, IWS1, HISTONE CHAPERONE, MRNA EXPORT 
5bo4:A    (THR54) to   (LYS134)  STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS  |   SIGNALING PROTEIN, UBIQUITIN LIGASE, SUPPRESSOR OF CYTOKINE SIGNALLING 
5bo4:M    (LEU62) to   (LYS134)  STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS  |   SIGNALING PROTEIN, UBIQUITIN LIGASE, SUPPRESSOR OF CYTOKINE SIGNALLING 
2jyq:A    (ARG12) to    (HIS90)  NMR STRUCTURE OF THE APO V-SRC SH2 DOMAIN  |   PROTEIN, SRC, SH2, SRC HOMOLOGY 2, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, ONCOGENE, PHOSPHOPROTEIN, SH2 DOMAIN, SH3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
1k9a:A    (THR88) to   (ASP159)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION  |   CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE 
1k9a:B    (THR88) to   (ASP159)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION  |   CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE 
1k9a:C    (GLU90) to   (ASP159)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION  |   CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE 
1k9a:D    (ARG89) to   (THR157)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION  |   CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE 
1k9a:E    (ARG89) to   (ASP159)  CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION  |   CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE 
1ka6:A    (SER12) to    (GLN88)  SAP/SH2D1A BOUND TO PEPTIDE N-PY  |   SH2 DOMAIN, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM 
1kc2:A   (THR156) to   (HIS235)  STRUCTURE OF THE TRIPLE (LYS(BETA)D3ALA, ASP(BETA)C8ALA, ASPCD2ALA) MUTANT OF THE SRC SH2 DOMAIN BOUND TO THE PQPYEEIPI PEPTIDE  |   SH2 DOMAIN, PHOSPHOTYROSINE, TRANSFERASE 
2l3t:A    (ASN14) to   (SER104)  SOLUTION STRUCTURE OF TANDEM SH2 DOMAIN FROM SPT6  |   SH2, SPT6, TRANSCRIPTION 
2l3t:A   (LYS112) to   (HIS195)  SOLUTION STRUCTURE OF TANDEM SH2 DOMAIN FROM SPT6  |   SH2, SPT6, TRANSCRIPTION 
2lxp:A     (GLY3) to   (ALA128)  NMR STRUCTURE OF TWO DOMAINS IN UBIQUITIN LIGASE GP78, RING AND G2BR, BOUND TO ITS CONJUGATING ENZYME UBE2G  |   RING DOMAIN, UBIQUITIN, LIGASE 
1x27:D   (SER133) to   (ALA212)  CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS  |   LCK-CAS COMPLEX, LCK PHOSPHO-PEPTIDE COMPLEX, HIGH AFFINITY LCK-CAS COMPLEX, SIGNALING PROTEIN 
2mk2:A    (SER19) to    (PRO97)  SOLUTION NMR STRUCTURE OF N-TERMINAL DOMAIN (SH2 DOMAIN) OF HUMAN INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE PROTEIN 1 (INPPL1) (FRAGMENT 20-117), NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR9134A  |   STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, HYDROLASE 
4nwf:A   (SER118) to   (PRO201)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION  |   HYDROLASE 
4nwf:B   (SER118) to   (PRO201)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION  |   HYDROLASE 
4nwg:B   (GLU121) to   (PRO201)  CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION  |   HYDROLASE 
2mqi:A   (GLY155) to   (ARG234)  HUMAN FYN SH2 FREE STATE  |   SH2 DOMAIN, FYN KINASE, SRC KINASE, TRANSFERASE 
2mrk:A   (LYS157) to   (ARG234)  FYN SH2 DOMAIN IN COMPLEX WITH THE NATURAL INHIBITORY PHOSPHOTYROSINE PEPTIDE  |   PHOSPHORYLATED PEPTIDE, FYN KINASE, SH2 DOMAIN, SRC KINASE, TRANSFERASE 
3k2m:A   (SER152) to   (VAL224)  CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX  |   ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, ATP-BINDING, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, SIGNALING PROTEIN, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX 
4ohd:A    (THR12) to    (TYR81)  LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT  |   SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE 
1mil:A    (SER15) to    (ASP82)  TRANSFORMING PROTEIN  |   SH2 DOMAIN, PHOSPHORYLATION, COLLAGEN, GROWTH REGULATION, TRANSFORMING PROTEIN, ALTERNATIVE INITIATION 
1y57:A   (THR154) to   (HIS233)  STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR  |   KINASE STRUCTURE, SH3, SH2, TRANSFERASE 
4po6:A   (GLU457) to   (GLN534)  CRYSTAL STRUCTURE OF THE HUMAN TYK2 FERM AND SH2 DOMAINS WITH AN IFNAR1 INTRACELLULAR PEPTIDE  |   FERM, SH2, KINASE, RECEPTOR, CYTOKINE, INTRACELLULAR, TRANSFERASE 
5eg3:B   (THR674) to   (LYS743)  CRYSTAL STRUCURE OF THE ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH THE CSH2 DOMAIN OF PHOSPHOLIPASE C GAMMA (PLCGAMMA)  |   SIGNALING COMPLEX, TYROSINE KINASE DOMAIN, SH2 DOMAIN, RECRUITMENT, PHOSPHORYLATION, TRANSFERASE-HYDROLASE COMPLEX 
3maz:A   (SER183) to   (ARG261)  CRYSTAL STRUCTURE OF THE HUMAN BRDG1/STAP-1 SH2 DOMAIN IN COMPLEX WITH THE NTAL PTYR136 PEPTIDE  |   MODULAR DOMAIN, PHOSPHOTYROSINE, SPECIFICITY, CYTOPLASM, PHOSPHOPROTEIN, SH2 DOMAIN, SIGNALING PROTEIN 
3bkb:A   (ARG467) to   (GLN534)  CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)  |   FES, V-FES, FUJINAMI, AVIAN SARCOMA, VIRAL, ONCOGENE, FELINE SARCOMA VIRUS, SGC, STRUCTURAL GENOMICS CONSORTIUM, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE 
3nhn:A   (SER154) to   (LYS232)  CRYSTAL STRUCTURE OF THE SRC-FAMILY KINASE HCK SH3-SH2-LINKER REGULATORY REGION  |   HCK, SH3-SH2-LINKER, SRC FAMILY KINASE, SFK, TRANSFERASE 
4u5w:B   (SER154) to   (GLY233)  CRYSTAL STRUCTURE OF HIV-1 NEF-SF2 CORE DOMAIN IN COMPLEX WITH THE SRC FAMILY KINASE HCK SH3-SH2 TANDEM REGULATORY DOMAINS  |   HCK, SH3-SH2 REGULATORY DOMAINS, SH3, SH2, SRC FAMILY KINASE, SFK, HIV-1, NEF, VIRUS, PROTEIN-PROTEIN COMPLEX, NEF-HCK COMPLEX, VIRAL PROTEIN-TRANSFERASE COMPLEX 
4u5w:D   (SER154) to   (GLY233)  CRYSTAL STRUCTURE OF HIV-1 NEF-SF2 CORE DOMAIN IN COMPLEX WITH THE SRC FAMILY KINASE HCK SH3-SH2 TANDEM REGULATORY DOMAINS  |   HCK, SH3-SH2 REGULATORY DOMAINS, SH3, SH2, SRC FAMILY KINASE, SFK, HIV-1, NEF, VIRUS, PROTEIN-PROTEIN COMPLEX, NEF-HCK COMPLEX, VIRAL PROTEIN-TRANSFERASE COMPLEX 
5i6v:A    (THR12) to    (HIS84)  STRUCTURE OF F285S, A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2  |   SHP2, CANCER-ASSOCIATED MUTATION, INHIBITORS, HYDROLASE 
4e93:A   (PRO466) to   (GLN534)  CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)IN COMPLEX WITH TAE684  |   V-FES, FUJINAMI, AVIAN SARCOMA, VIRAL, ONCOGENE, FELINE SARCOMA VIRUS, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3psj:A  (GLY1264) to  (SER1353)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM SE-SPT6 (1247-1451)  |   TANDEM SH2, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psj:A  (LYS1361) to  (SER1440)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM SE-SPT6 (1247-1451)  |   TANDEM SH2, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:A  (GLY1264) to  (SER1353)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:A  (THR1360) to  (SER1440)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:B  (LYS1361) to  (SER1440)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:C  (ARG1265) to  (ILE1336)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:C  (THR1360) to  (GLY1433)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
3psk:D  (ARG1265) to  (SER1353)  CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451)  |   TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION 
4ey0:A   (THR674) to   (HIS744)  STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1  |   SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE 
4ey0:B   (THR674) to   (HIS744)  STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1  |   SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE 
4ey0:C   (THR674) to   (HIS744)  STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1  |   SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE 
4ey0:D   (THR674) to   (HIS744)  STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1  |   SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE 
4f5a:A   (THR157) to   (HIS236)  TRIPLE MUTANT SRC SH2 DOMAIN BOUND TO PHOSPHATE ION  |   SH2 DOMAIN, CELL SIGNALLING, PHOSPHOTYROSINE, PROTEIN BINDING 
4f5b:A   (THR157) to   (HIS236)  TRIPLE MUTANT SRC SH2 DOMAIN BOUND TO PHOSPHOTYROSINE  |   SH2 DOMAIN, CELL SIGNALLING, PHOSPHOTYROSINE, PROTEIN BINDING 
4fbn:A   (THR674) to   (PRO745)  INSIGHTS INTO STRUCTURAL INTEGRATION OF THE PLCGAMMA REGULATORY REGION AND MECHANISM OF AUTOINHIBITION AND ACTIVATION BASED ON KEY ROLES OF SH2 DOMAINS  |   SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE 
3qwx:X    (SER20) to   (LYS100)  CED-2 1-174  |   CELL ENGULFMENT, SIGNALING PROTEIN 
3qwy:B    (SER20) to   (VAL103)  CED-2  |   CELL ENGULFMENT, SIGNALING PROTEIN 
5l04:A   (GLN455) to   (LYS527)  STRUCTURE OF INTERFERON LAMBDA 1 RECEPTOR WITH HUMAN KINASE JAK1  |   COMPLEX OF JAK1 AND INTERFERON LAMBDA 1, JAK KINASE, INTRACELLULAR DOMAIN OF IFNLR1, FERM DOMAIN, SH2-LIKE DOMAIN, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX 
1bfi:A    (ASN17) to    (THR88)  SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE, NMR, 30 STRUCTURES  |   SH2 DOMAIN, P85ALPHA, PI 3-KINASE, NMR, C TERMINAL SH2 DOMAIN 
2c0t:B   (SER129) to   (GLY208)  SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359  |   TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, SH2 DOMAIN, SH3 DOMAIN 
4jeg:A   (SER118) to   (ASN200)  CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX  |   ENGINEERED BINDING PROTEIN, SHP2 SH2-MONOBODY COMPLEX, PHOSPHATASE, PHOSPHOTYROSINE BINDING, PHOSPHORYLATION, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX 
3gxx:A    (GLY18) to    (ILE98)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxx:B    (GLY18) to    (ARG99)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxx:C    (LYS19) to   (GLU103)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxx:D    (LYS19) to   (GLU103)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxw:A    (GLY18) to   (LEU100)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxw:B    (GLY18) to   (LEU100)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxw:C    (GLY18) to   (LEU101)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3gxw:D    (GLY18) to   (ASN102)  STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A  |   SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION 
2dvj:A    (SER19) to   (TYR104)  PHOSPHORYLATED CRK-II  |   SH3, SH2, SIGNAL TRANSDUCTION, ADAPTER MOLECULE, SIGNALING PROTEIN 
2eyv:A    (ARG20) to   (TYR104)  SH2 DOMAIN OF CT10-REGULATED KINASE  |   SH2, SIGNALING PROTEIN 
2gsb:A    (LEU31) to    (GLU96)  SOLUTION STRUCTURE OF THE SECOND SH2 DOMAIN OF HUMAN RAS GTPASE-ACTIVATING PROTEIN 1  |   GTPASE-ACTIVATING PROTEIN, GAP, RAS P21 PROTEIN ACTIVATOR, P120GAP, RASGAP, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
2h8h:A   (THR154) to   (HIS233)  SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR  |   SRC KINASE, TRANSFERASE 
3vry:B   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL- CYCLOPENTANE  |   TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3vs0:B   (SER155) to   (GLY234)  CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE  |   KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
2mrj:A   (LEU154) to   (SER232)  STRUCTURE OF FYN PROTEIN SH2 BOUND  |   FYN KINASE, SRC KINASE, SH2 DOMAIN, TRANSFERASE 
2ysx:A    (THR18) to    (LYS94)  SOLUTION STRUCTURE OF THE HUMAN SHIP SH2 DOMAIN  |   SH2 DOMAIN, PHOSPHOTYROSINE BINDING DOMAIN, PROTEIN TYROSINE KINASE, SIGNAL TRANSDUCTION, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
4dgx:A    (THR12) to    (GLU83)  LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT  |   HYDROLASE 
4eih:A   (LEU187) to   (SER249)  CRYSTAL STRUCTURE OF ARG SH2 DOMAIN  |   SH2 DOMAIN, PROTEIN/PROTEIN INTERACTION, PHOSPHOTYROSINE, PHOSPHOPEPTIDE, TRANSFERASE 
4fl2:A   (SER174) to   (ALA248)  STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH  |   TRANSFERASE, PROTEIN KINASE 
4fl3:A   (SER174) to   (ALA248)  STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH  |   TRANSFERASE, PROTEIN KINASE